MedTrace Logo

Treatment With PTH After Sternotomy in Cardiac Surgery Patients

NCT01466829 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-06-02

No results posted yet for this study

Summary

The aims of this study is to compare healing time and quality of newly formed bone in cardiac surgery patients treated with PTH post-surgically and a control group treated with saline.

Conditions

  • Disruption or Dehiscence of Closure of Sternum or Sternotomy

Interventions

DRUG

Parathyroid hormone

100 microgram daily. S.c

DRUG

Placebo

Placebo; saline injection.

Sponsors & Collaborators

  • Takeda

    collaborator INDUSTRY

  • Aarhus University Hospital

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Per Nielsen, MD · Dept. of Cardiothoracic & Vascular Surgery, Aarhus University Hospital, Skejby

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01466829 on ClinicalTrials.gov